An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

Inclusion Criteria: * Diagnosis of Crohn's disease made at least 3 months prior to study entry. * C-reactive protein above the upper limit of normal. * Currently have moderately active Crohn's disease. Exclusion Criteria: * Women who are pregnant or lactating or of childbearing potential. * History of colostomy, ileostomy, intestinal resection resulting in short bowel syndrome or symptomatic strictures. * Symptoms (abdominal pain, vomiting) and radiographic evidence of mechanical bowel obstruction within the previous 6 months. * Fistulizing disease. * Positive stool culture for enteric pathogens and/or C. difficile toxin. * History of significant disease.